Description:Panacea Venture is a distinguished life sciences venture capital firm that operates with a global vision, establishing a presence across three continents. Founded in 2017, the firm is currently managing four investment funds, which focus on early-stage companies through public investments. Panacea Venture is dedicated to incubating innovative early-stage companies that possess breakthrough technologies and discoveries aimed at addressing unmet medical needs. Their objective is to enhance the quality of life on a global scale.
The investment team at Panacea Venture boasts more than 100 years of combined investing experience. This wealth of expertise is further augmented by the contributions of venture partners and advisors, who collectively provide extensive coverage across both emerging and established sectors, including biotechnology, diagnostics, and medical technology (medtech). The highly experienced team at Panacea Venture has established a robust track record of successfully guiding portfolio companies toward their goals, ensuring that their innovative solutions reach those who can benefit from them. Through their commitment to fostering technological advancement in the life sciences, Panacea Venture continues to play a pivotal role in shaping the future of healthcare and improving lives worldwide.